Xanthone derivatives for the treatment of hepatitis B virus disease
US10611748B2 · kind B2 · utility
0Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 26, 2018 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Nov 26, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds having the general formula:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.